The deal may be valued at around $100 million and fits in with Aurobindo’s strategic road map of upping its presence in eastern Europe through bolt-on acquisitions, two sources told ET. I-bankers did not rule out other Indian bidders, but no clear names were disclosed.
Aurobindo did not respond to an email from ET till press time. Response from Apotex is awaited to a detailed questionnaire sent over a week ago.
Read More News on
Download The Economic Times News App to get Daily Market Updates & Live Business News.
Read More News on
Download The Economic Times News App to get Daily Market Updates & Live Business News.